INOVIO Provides an Update on Lassa Fever and MERS Programs
PLYMOUTH MEETING, Pa., Nov. 17, 2022 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and prevent infectious diseases, cancer, and diseases associated with HPV, today... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - November 17, 2022 Category: Pharmaceuticals Source Type: clinical trials
Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial
DiscussionThis trial will determine whether CCP will reduce intubation or death non-intubated adults with COVID-19. The trial will also provide information on the role of and thresholds for SARS-CoV-2 antibody titres and neutralization assays for donor qualification.Trial registrationClinicaltrials.govNCT04348656. Registered on 16 April 2020. (Source: Trials)
Source: Trials - May 4, 2021 Category: Research Source Type: clinical trials
Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria
Conditions: Travel-Related Illness; Malaria; Dengue; Chikungunya; Zika; SARS-CoV Infection; MERS; Influenza; Diarrhea Intervention: Other: Observational study Sponsors: Patricia Schlagenhauf; ETH Zurich; Swiss Tropical & Public Health Institute; University Hospital, Geneva; Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 17, 2020 Category: Research Source Type: clinical trials
Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers
Condition: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Interventions: Drug: INO-4700; Drug: Placebo; Device: CELLECTRA™ 2000 Sponsors: Inovio Pharmaceuticals; Coalition for Epidemic Preparedness Innovations (CEPI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2020 Category: Research Source Type: clinical trials
